RECRUITING

Survivorship Plan HEalth REcord (SPHERE) Implementation Trial

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To understand the effectiveness and implementation of the SCP-PHR, we will conduct a hybrid type 1 effectiveness-implementation trial consisting of the following components: (A) a randomized clinical effectiveness trial, and (B) a mixed methods implementation study.

Official Title

Survivorship Plan HEalth REcord (SPHERE) Implementation Trial

Quick Facts

Study Start:2022-09-09

Study Completion:2026-05-31

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT05346796

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 99 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
1. Patients must be 18 years or older at the time of consent 2. Patients must have regular (at least weekly) access to an internet connection, whether at home or elsewhere (family or friend). 3. Diagnosis of colon or rectal cancer, Stages I, II, or III (AJCC, American Joint Committee on Cancer) and have undergone initial curative-intent therapy for their CRC diagnosis within the past 12 months. 4. English-speaking	1. Patient will be excluded if they have had recurrence of their colorectal cancer. 2. Patient's with severe cognitive impairment 3. Patient's with schizophrenia or other psychosis 4. Patients currently in hospice care

Inclusion Criteria

Exclusion Criteria

1. Patients must be 18 years or older at the time of consent
2. Patients must have regular (at least weekly) access to an internet connection, whether at home or elsewhere (family or friend).
3. Diagnosis of colon or rectal cancer, Stages I, II, or III (AJCC, American Joint Committee on Cancer) and have undergone initial curative-intent therapy for their CRC diagnosis within the past 12 months.
4. English-speaking

1. Patient will be excluded if they have had recurrence of their colorectal cancer.
2. Patient's with severe cognitive impairment
3. Patient's with schizophrenia or other psychosis
4. Patients currently in hospice care

Contacts and Locations

Study Contact

David A Haggstrom, MD

CONTACT

(317) 274-9000

dahaggst@iu.edu

Study Locations (Sites)

Indiana University School of Medicine

Indianapolis, Indiana, 46202

United States

Collaborators and Investigators

Sponsor: Indiana University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-09-09

Study Completion Date2026-05-31

Study Record Updates

Study Start Date2022-09-09

Study Completion Date2026-05-31

Terms related to this study

Additional Relevant MeSH Terms

Cancer